Recent advances in the understanding of trimeric autotransporter adhesins.

Adhesins Autotransport Autotransporter BAM Bacterial outer membrane proteins Bacterial proteins BpaC Burkholderia pseudomallei Gram-negative bacteria Outer membrane Protein export Protein folding Protein secretion Protein structure Protein translocation Protein transport Transmembrane β-barrel Trimeric autotransporter adhesins (TAAs) Type V secretion Virulence factors/chemistry

Journal

Medical microbiology and immunology
ISSN: 1432-1831
Titre abrégé: Med Microbiol Immunol
Pays: Germany
ID NLM: 0314524

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 12 08 2019
accepted: 30 11 2019
pubmed: 23 12 2019
medline: 11 2 2021
entrez: 23 12 2019
Statut: ppublish

Résumé

Adhesion is the initial step in the infection process of gram-negative bacteria. It is usually followed by the formation of biofilms that serve as a hub for further spread of the infection. Type V secretion systems engage in this process by binding to components of the extracellular matrix, which is the first step in the infection process. At the same time they provide protection from the immune system by either binding components of the innate immune system or by establishing a physical layer against aggressors. Trimeric autotransporter adhesins (TAAs) are of particular interest in this family of proteins as they possess a unique structural composition which arises from constraints during translocation. The sequence of individual domains can vary dramatically while the overall structure can be very similar to one another. This patchwork approach allows researchers to draw conclusions of the underlying function of a specific domain in a structure-based approach which underscores the importance of solving structures of yet uncharacterized TAAs and their individual domains to estimate the full extent of functions of the protein a priori. Here, we describe recent advances in understanding the translocation process of TAAs and give an overview of structural motifs that are unique to this class of proteins. The role of BpaC in the infection process of Burkholderia pseudomallei is highlighted as an exceptional example of a TAA being at the centre of infection initiation.

Identifiants

pubmed: 31865405
doi: 10.1007/s00430-019-00652-3
pii: 10.1007/s00430-019-00652-3
pmc: PMC7247746
doi:

Substances chimiques

Adhesins, Bacterial 0
Type V Secretion Systems 0
Virulence Factors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-242

Subventions

Organisme : Horizon 2020
ID : 765042
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M023281/1
Pays : United Kingdom

Références

Harefuah. 2002 May;141 Spec No:88-91, 119
pubmed: 12170562
PLoS Pathog. 2008 Aug 08;4(8):e1000119
pubmed: 18688279
Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):20907-12
pubmed: 23213248
BMC Microbiol. 2014 Apr 14;14:92
pubmed: 24731253
J Biol Chem. 2015 Apr 17;290(16):10104-16
pubmed: 25670852
Vaccine. 2019 May 21;37(23):3113-3122
pubmed: 31029515
Nature. 1987 Jan 29-Feb 4;325(6103):458-62
pubmed: 3027577
J Struct Biol. 2006 Aug;155(2):306-15
pubmed: 16765057
Nat Commun. 2017 Nov 3;8(1):1309
pubmed: 29101319
Infect Immun. 2005 Aug;73(8):5127-36
pubmed: 16041029
Nat Methods. 2012 Dec;9(12):1212-7
pubmed: 23142870
Infect Immun. 2011 Jul;79(7):2544-53
pubmed: 21536788
Mol Microbiol. 2019 Mar;111(3):844-862
pubmed: 30600549
Infect Immun. 2005 Apr;73(4):2400-10
pubmed: 15784586
J Bacteriol. 2019 Jul 24;201(16):
pubmed: 31160398
Cold Spring Harb Perspect Biol. 2010 May;2(5):a000414
pubmed: 20452953
J Mol Biol. 2007 Nov 16;374(1):91-105
pubmed: 17928002
Annu Rev Microbiol. 2007;61:89-112
pubmed: 17506669
J Bacteriol. 2009 Oct;191(20):6300-11
pubmed: 19684128
Annu Rev Microbiol. 2010;64:495-517
pubmed: 20528691
Infect Immun. 2001 Dec;69(12):7293-303
pubmed: 11705900
Mol Microbiol. 2009 Mar;71(5):1323-32
pubmed: 19170888
J Biol Chem. 2014 Mar 14;289(11):7388-98
pubmed: 24369174
Science. 2016 Jan 8;351(6269):180-6
pubmed: 26744406
Biophys J. 2016 Jun 21;110(12):2698-2709
pubmed: 27332128
Clin Microbiol Rev. 2002 Apr;15(2):155-66
pubmed: 11932228
Microbiology. 2007 Jan;153(Pt 1):59-70
pubmed: 17185535
Mol Membr Biol. 2006 Nov-Dec;23(6):499-508
pubmed: 17127622
Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17739-44
pubmed: 20876094
Trends Microbiol. 2006 Jun;14(6):264-70
pubmed: 16678419
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):E938-47
pubmed: 23431155
PLoS One. 2010 Sep 20;5(9):
pubmed: 20862217
J Bacteriol. 2008 Jun;190(12):4147-61
pubmed: 18424525
Genome Biol Evol. 2015 May 20;7(6):1628-43
pubmed: 25994932
Structure. 2011 Jul 13;19(7):1021-30
pubmed: 21742268
PLoS One. 2015 Apr 01;10(4):e0121271
pubmed: 25830295
Bioinformatics. 2008 May 15;24(10):1251-6
pubmed: 18397894
mBio. 2018 Oct 16;9(5):
pubmed: 30327444
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):E4246-55
pubmed: 24145447
Acta Crystallogr D Biol Crystallogr. 2015 Nov;71(Pt 11):2227-35
pubmed: 26527140
Front Microbiol. 2016 Dec 20;7:2004
pubmed: 28066340
Nat Rev Microbiol. 2006 Apr;4(4):272-82
pubmed: 16541135
Microbiol Mol Biol Rev. 2004 Dec;68(4):692-744
pubmed: 15590781
Cell Microbiol. 2012 Feb;14(2):198-209
pubmed: 21981119
Biotechnol J. 2019 Apr;14(4):e1800359
pubmed: 30179307
Science. 2007 Aug 17;317(5840):961-4
pubmed: 17702946
Trends Microbiol. 2005 Jan;13(1):34-40
pubmed: 15639630
Clin Vaccine Immunol. 2009 Oct;16(10):1420-8
pubmed: 19692625
Nat Struct Mol Biol. 2012 Apr 01;19(5):506-10, S1
pubmed: 22466966
Mol Microbiol. 2016 Dec;102(5):753-756
pubmed: 27618357
J Bacteriol. 2003 Jul;185(13):3735-44
pubmed: 12813066
Sci Rep. 2017 Apr 06;7:45929
pubmed: 28383523
J Bacteriol. 2012 Feb;194(4):827-38
pubmed: 22155776
Nat Biotechnol. 2018 Jan;36(1):103-112
pubmed: 29176613
Mol Microbiol. 2005 Feb;55(3):687-98
pubmed: 15660996
J Biol Chem. 2015 Jan 16;290(3):1837-49
pubmed: 25488660
J Bacteriol. 2006 Aug;188(15):5400-7
pubmed: 16855229
Int J Med Microbiol. 2015 Feb;305(2):265-75
pubmed: 25583454
J Biol Chem. 2010 Dec 3;285(49):38224-33
pubmed: 20923769
Mol Membr Biol. 2005 Jan-Apr;22(1-2):63-72
pubmed: 16092525
EMBO J. 1990 Jun;9(6):1991-9
pubmed: 2189728
EMBO J. 2000 Nov 15;19(22):5989-99
pubmed: 11080146
FEMS Microbiol Rev. 2012 Nov;36(6):1023-45
pubmed: 22250915

Auteurs

Andreas R Kiessling (AR)

Astbury Centre for Structural Molecular Biology, School of Biomedical Science, University of Leeds, Leeds, LS2 9JT, England, UK.

Anchal Malik (A)

Astbury Centre for Structural Molecular Biology, School of Biomedical Science, University of Leeds, Leeds, LS2 9JT, England, UK.

Adrian Goldman (A)

Astbury Centre for Structural Molecular Biology, School of Biomedical Science, University of Leeds, Leeds, LS2 9JT, England, UK. a.goldman@leeds.ac.uk.
Faculty of Biological and Environmental Sciences, University of Helsinki, FIN-0014, Helsinki, Finland. a.goldman@leeds.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH